Intracellular pathways following uptake of bevacizumab in RPE cells

Experimental Eye Research

Volumn 131, Issue , 2015, Pages 29-41

  Aboul Naga, Shereen Hassan ^a,b   Dithmer, Michaela ^a   Chitadze, Guranda ^a   Kabelitz, Dieter ^a   Lucius, Ralph ^c   Roider, Johann ^a   Klettner, Alexa ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Actin filament; Bevacizumab; DMEM; DMSO; Exosomes; Myosin7a; PBS; PFA; Retinal pigment epithelium; RPE; VEGF

Indexed keywords

BEVACIZUMAB; F ACTIN; MYOSIN VIIA; RAB PROTEIN; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ACTIN FILAMENT; ANIMAL CELL; ARPE19 CELL LINE; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; ENDOSOME; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; NONHUMAN; PIGMENT EPITHELIUM; PRIMARY CELL LINE; RETINA PIGMENT CELL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR FLUID; MACULAR DEGENERATION; METABOLISM; PATHOLOGY; SWINE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXOSOMES; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR FLUID; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919935150     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.12.010     Document Type: Article

References (53)

1. Ashiru O., Boutet P., Fernández-Messina L., Agüera-González S., Skepper J.N., Valés-Gómez M., Reyburn H.T. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 2010, 70:481-489.
2. Bhat S.P., Gangalum R.K. Secretion of αB-Crystallin via exosomes: new clues to the function of human retinal pigment epithelium. Commun. Integr. Biol. 2011, 4:739-741.
3. Biasutto L., Chiechi A., Couch R., Liotta L.A., Espina V. Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. Exp. Cell Res. 2013, 319:2113-2123.
4. Bucci C., Parton R.G., Mather I.H., Stunnenberg H., Simons K., Hoflack B., Zerial M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 1992, 70:715-728.
5. Bucci C., Thomsen P., Nicoziani P., McCarthy J., van Deurs B. Rab7: a key to lysosome biogenesis. Mol. Biol. Cell 2000, 11:467-480.
6. Campochiaro P.A. Anti-vascular endothelial growth factor treatment for retinal vein occlusion. Ophthalmologica 2012, (Suppl.1):30-35.
7. Chaitin M., Hall M.O. The distribution of actin in cultured normal and dystrophic rat pigment epithelial cells during phagocytosis of rod outer segments. Investig. Ophthalmol. Vis. Sci. 1983, 24:821-831.
8. Chakravarthy U., Harding S.P., Rogers C.A., Downes S.M., Lotery A.J., Wordsworth S., Reeves B. Ranibizumab versus bevacizumab to treat neovasculare age-related macular degeneration - one year findings from the IVAN randomized trial. Ophthalmology 2012, 119:1399-1411.
9. Chitadze G., Lettau M., Bhat J., Wesch D., Steinle A., Fürst D., Mytilineos J., Kalthoff H., Janssen O., Oberg H.H., Kabelitz D. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17. Int. J. Cancer 2013, 133:1557-1566.
10. Deissler H.L., Deissler H., Lang G.E. Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences. Br. J. Ophthalmol. 2012, 96:1023-1028.
11. Dithmer M., Fuchs S., Shi Y., Schmidt H., Richert E., Roider J., Klettner A. Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis invitro. PLoS One 2014, 9:e89150.
12. El-Amraoui A., Schonn J.S., Küssel-Andermann P., Blanchard S., Desnos C., Henry J.P., et al. MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes. EMBO Rep. 2002, 3:463-470.
13. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J.Biol. Chem. 1998, 273:20121-20127.
14. Feng Y., Press B., Wandinger-Ness A. Rab 7: an important regulator of late endocytic membrane traffic. J.Cell Biol. 1995, 131:1435-1452.
15. Fujimoto L.M., Roth R., Heuser J.E., Schmid S.L. Actin assembly plays a variable, but not obligatory role in receptor-mediated endocytosis in mammalian cells. Traffic 2000, 1:161-171.
16. Futter C. The molecular regulation of organelle transport in mammalian retinal pigment epithelia cells. Pigment Cell Res. 2006, 19:104-111.
17. Gibbs D., Kitamoto J., Williams D.S. Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6481-6486.
18. Gottlieb T.A., Ivanov I.E., Adesnik M., Sabatini D.D. Actin microfilaments play a critical role in endocytosis at the apical but not the basolateral surface of polarized epithelial cells. J.Cell Biol. 1993, 120:695-710.
19. Grapp M., Wrede A., Schweizer M., Hüwel S., Galla H.J., Snaidero N., Simons M., Bückers J., Low P.S., Urlaub H., Gärtner J., Steinfeld R. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat. Commun. 2013, 4:2123.
20. Haley J.E., Flood M.T., Gouras P., Kjeldhye H.M. Proteins from human retinal pigment epithelial cells: evidence that a major protein is actin. Investig. Ophthalmol. Vis. Sci. 1983, 24:803-811.
21. Heiduschka P., Fietz H., Hofmeister S., Schultheiss S., Mack A.F., Peters S., Ziemssen F., Niggemann B., Julien S., Bartz-Schmidt K.U., Schraermeyer U. Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Investig. Ophthalmol. Vis. Sci. 2007, 48:2814-2823. Tübingen Bevacizumab Study Group.
22. Hoppe G., Marmorstein A.D., Pennock E.A., Hoff H.F. Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE. Investig. Ophthalmol. Vis. Sci. 2001, 42:2714-2720.
23. Julien S., Biesemeier A., Taubitz T., Schraermeyer U. Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes. Br. J. Ophthalmol. 2014, 98:813-825.
24. Kivinen N., Dithmer M., Kinnunen K., Lucius R., Roider J., Kaarniranta K., Klettner A. Bevacizumab does not affect autophagy clearance during proteasomal inhibition in human retinal pigment epithelial cells. J.Biochem. Pharmacol. Res. 2014, 2:44-53.
25. Klettner A., Roider J. Comparison of bevacizumab, ranibizumab, and pegaptanib invitro: efficiency and possible additional pathways. Investig. Ophthalmol. Vis. Sci. 2008, 49:4523-4527.
26. Klettner A.K., Kruse M.L., Meyer T., Wesch D., Kabeliltz D., Roider J. Different properties of VEGF-antagonists: Bevacizumab but not ranibizumab accumulates in RPE cells. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:1601-1608.
27. Klettner A., Roider J. Treating age-related macular degeneration - interaction of VEGF-antagonists with their target. Mini Rev. Med. Chem. 2009, 9:1127-1135.
28. Klettner A., Möhle F., Roider J. Intracellular bevacizumab reduces phagocytotic uptake in RPE cells. Graefes Arch. Clin. Exp. Ophthalmol. 2010, 248:819-824.
29. Klettner A., Westhues D., Lassen J., Bartsch S., Roider J. Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. Mol. Vis. 2013, 19:281-291.
30. Klettner A. VEGF-A and its inhibitors in age-related macular degeneration - pharmacokinetic differences and their retinal and systemic implications. J.Biochem. Pharmacol. Res. 2014, 2:8-20.
31. Klettner A., Tahmaz N., Dithmer M., Richert E., Roider J. Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis. Br. J. Ophthalmol. 2014, 98:1448-1452.
32. Krohne T.U., Holz F.G., Meyer C.H. Pharmacokinetics of intravitreally administered VEGF inhibitors. Ophthalmologe 2014, 111:113-120.
33. Lally D.R., Gerstenblith A.T., Regillo C.D. Preferred therapies for neovascular age-related macular degeneration. Curr. Opin. Ophthalmol. 2012, 23:182-188.
34. Lang G.E. Diabetic macular edema. Ophthalmologica 2012, 227:21-29.
35. Lopes V.S., Gibbs D., Libby R.T., Aleman T.S., Welch D.L., Lillo C., Jacobson S.G., Radu R.A., Steel K.P., Williams D.S. The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65. Hum. Mol. Genet. 2011, 20:2560-2570.
36. Ludwig A.K., Giebel B. Exosomes: small vesicles participating in intercellular communication. Int. J. Biochem. Cell Biol. 2012, 44:11-15.
37. Martin D.F., Maguire M.G., Ying G.S., Grunwald J.E. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N.Engl. J. Med. 2011, 364:1897-1908. CATT Research Group.
38. Matsumoto B., Guerin C.J., Anderson D.H. Cytoskeletal redifferentiation of feline, monkey and human RPE cells in culture. Investig. Ophthalmol. Vis. Sci. 1990, 31:879-889.
39. Miura Y., Roider J. Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:641-649.
40. Miura Y., Klettner A., Roider J. VEGF antagonists decrease barrier function of retinal pigment epithelium invitro: possible participation of intracellular glutathione. Investig. Ophthalmol. Vis. Sci. 2010, 51:4848-4855.
41. Niu N., Zhang J., Sun Y., Wang S., Sun Y., Korteweg C., Gao W., Gu J. Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye. Cell. Mol. Life Sci. 2011, 68:2481-2492.
42. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J.Cell Biol. 2013, 200:373-383.
43. Record M., Subra C., Silvente-Poirot S., Poirot M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 2011, 81:1171-1182.
44. Soni L.E., Warren C.M., Bucci C., Orten D.J., Hasson T. The unconventional myosin-VIIa associates with lysosomes. Cell Motil. Cytoskelet. 2005, 62:13-26.
45. Sreekumar P.G., Kannan R., Kitamura M., Spee C., Barron E., Ryan S.J., Hinton D.R. αB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS One 2010, 5:e12578.
46. Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev. 2005, 85:845-881.
47. Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol. Rep. 2011, 3:15.
48. Tse S.M., Furuya W., Gold E., Schreiber A.D., Sandvig K., Inman R.D., Grinstein S. Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosis. J.Biol. Chem. 2003, 278:3331-3338.
49. van Bilsen K., van Hagen P.M., Bastiaans J., van Meurs J.C., Missotten T., Kuijpers R.W., Hooijkaas H., Dingjan G.M., Baarsma G.S., Dik W.A. The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha. Br. J. Ophthalmol. 2011, 95:864-868.
50. Wang A.L., Lukas T.J., Yuan M., Du N., Tso M.O., Neufeld A.H. Autophagy, exosomes and drusen formation in age-related macular degeneration. Autophagy 2009, 5:563-564.
51. Wittchen E.S., Haskins J., Stevenson B.R. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J.Biol. Chem. 1999, 274:35179-35185.
52. Woodman P.G. Biogenesis of the sorting endosome: the role of Rab5. Traffic 2000, 1:695-701.
53. Zajac A.L., Goldman Y.E., Holzbaur E.L.F., Ostap E.M. Local cytoskeletal and organelle interactions impact molecular-motor-driven early endosome trafficking. Curr. Biol. 2013, 23:1173-1180.